Jiangsu Hengrui Medicine
600276.SS
#508
Rank
A$60.75 B
Marketcap
$9.52
Share price
-0.27%
Change (1 day)
0.45%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of June 2024 : A$4.80 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company has A$4.80 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$3.80 B-5.76%
2021-12-31A$4.04 B23.58%
2020-12-31A$3.26 B18.38%
2019-12-31A$2.76 B19.96%
2018-12-31A$2.30 B174.07%
2017-12-31A$0.84 B-14.39%
2016-12-31A$0.98 B-9.74%
2015-12-31A$1.08 B60.07%
2014-12-31A$0.67 B69.04%
2013-12-31A$0.40 B95.39%
2012-12-31A$0.20 B39.6%
2011-12-31A$0.14 B-0.88%
2010-12-31A$0.14 B28.39%
2009-12-31A$0.11 B17.1%
2008-12-31A$98.86 M-25.31%
2007-12-31A$0.13 B41.28%
2006-12-31A$93.69 M28.2%
2005-12-31A$73.08 M28.62%
2004-12-31A$56.81 M73.63%
2003-12-31A$32.72 M-20.26%
2002-12-31A$41.04 M-36.03%
2001-12-31A$64.15 M-38.61%
2000-12-31A$0.10 B471.37%
1999-12-31A$18.29 M223.03%
1998-12-31A$5.66 M15.62%
1997-12-31A$4.89 M